Yu Zhang

The cytoplasmic translocation of Cx32 mediates cisplatin resistance in ovarian cancer cells.

Yuexia Peng, Min-feng Shao, L. Tao, 2017, Biochemical and biophysical research communications.

Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway.

H. Ge, L. Tao, Hui Luo, 2019, Molecular medicine reports.